- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Boosting SARS-CoV-2 immunity in immunocompromised individuals ; day:19 ; month:12 ; year:2023 ; pages:1-2
Genes and immunity ; (19.12.2023), 1-2
- Creator
-
Müller, Thomas R.
Buggert, Marcus
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41435-023-00219-6
- URN
-
urn:nbn:de:101:1-2024030321015591071244
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Müller, Thomas R.
- Buggert, Marcus
- SpringerLink (Online service)
Other Objects (12)
Toxoplasma gondii infection in immunocompromised individuals
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
Heterologous vaccine interventions: boosting immunity against future pandemics
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
“Immune Boosting” in the time of COVID: selling immunity on Instagram
SARS-CoV-2 immunity in animal models
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Toxoplasma gondii infection in immunocompromised individuals
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
Heterologous vaccine interventions: boosting immunity against future pandemics
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
“Immune Boosting” in the time of COVID: selling immunity on Instagram
SARS-CoV-2 immunity in animal models
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Toxoplasma gondii infection in immunocompromised individuals
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
Heterologous vaccine interventions: boosting immunity against future pandemics
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
“Immune Boosting” in the time of COVID: selling immunity on Instagram
SARS-CoV-2 immunity in animal models